معرفی
Philippe Connes is a full Professor at Université Claude Bernard Lyon 1, where he leads the Vascular Biology and Red Blood Cell (VBRBC) team at the LIBM laboratory (EA7424). He previously held positions at the University of the French West Indies and served as a researcher at Inserm UMR 1134 in Guadeloupe. He is Vice-Dean of Doctorate School EDISS 205 and Scientific Research referent for the Constitutive Reference Center on Red Blood Cell Disorders in Lyon.
- PhD in Exercise Physiology and Hematology, Montpellier (2003)
- HDR, University of the French West Indies (2009)
- Junior Member, French University Institute (IUF) (2013)
His research focuses on the cellular and physiological mechanisms underlying sickle cell disease and other hematological disorders, including hereditary spherocytosis and chronic mountain sickness. He investigates blood rheology, vascular function, autonomic nervous system activity, inflammation, and the effects of exercise on red blood cell physiology in both healthy individuals and patients. His work integrates clinical, physiological, and molecular approaches to understand disease complications and improve therapeutic strategies.
The 15 most recent articles reflect a strong trend in sickle cell disease pathophysiology, red blood cell behavior, vascular dysfunction, and hemorheological adaptations to hypoxia and exercise. Key themes include inflammation, microcirculation, oxidative stress, and the role of nitric oxide metabolites. His publications span high-impact journals in hematology, physiology, and microcirculation.
- A.L. Copley Best Paper Prize 2019
- A.L. Copley Best Paper Prize 2020
- A.L. Copley Best Paper Prize 2023
- Junior Member, French University Institute (IUF)
Philippe Connes has supervised over 20 PhD and postdoctoral researchers and secured funding from diverse sources including the French National Research Agency (ANR), German Research Foundation (DFG), European H2020 programs, Marie-Curie ITN, and private pharmaceutical companies like Erytech Pharma and Hartis Pharma. He is actively involved in editorial work for Clinical Hemorheology and Microcirculation, Frontiers in Physiology, and PLOS ONE, and holds leadership roles in the European Society of Clinical Hemorheology and Microcirculation (ESCHM), the French Club of the Red Blood Cell and Iron, and the International Society for Clinical Hemorheology (ISCH).
He leads the VBRBC research team at LIBM, focusing on vascular biology and red blood cell disorders, with strong collaborations across national and international institutions.
